dc.contributorFaculdade de Medicina de Marília (FAMEMA)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:23:58Z
dc.date.accessioned2022-10-05T18:17:32Z
dc.date.available2014-05-27T11:23:58Z
dc.date.available2022-10-05T18:17:32Z
dc.date.created2014-05-27T11:23:58Z
dc.date.issued2009-09-21
dc.identifierCochrane Database of Systematic Reviews, n. 2, 2009.
dc.identifier1469-493X
dc.identifierhttp://hdl.handle.net/11449/71154
dc.identifier10.1002/14651858.CD007723
dc.identifier2-s2.0-70349089086
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3920369
dc.languageeng
dc.relationCochrane Database of Systematic Reviews
dc.relation6.754
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectallopurinol
dc.subjectalpha adrenergic receptor blocking agent
dc.subjectantibiotic agent
dc.subjectantiinflammatory agent
dc.subjectazasteroid
dc.subjectdutasteride
dc.subjectfinasteride
dc.subjectplacebo
dc.subjectchronic pain
dc.subjectchronic pelvic pain syndrome
dc.subjectchronic prostatitis
dc.subjectclinical trial
dc.subjectdisease severity
dc.subjectdrug efficacy
dc.subjectdrug safety
dc.subjecthuman
dc.subjectoutcome assessment
dc.subjectpelvis pain syndrome
dc.subjectreview
dc.titleEffectiveness and safety of finasteride in male chronic pelvic pain syndrome
dc.typeResenha


Este ítem pertenece a la siguiente institución